November 04 - 06, 2025 | Boston Convention and Exhibition Center, Boston, MA
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
November 04 - 06, 2025 | Boston Convention and Exhibition Center, Boston, MA
You have these already downloaded
We have sent you a copy of the report to your email again.
The World Drug Safety Congress Americas 2025 will be held from 4 to 6 November 2025 at the Boston Convention and Exhibition Center, Massachusetts. The event will once again unite more than 2,500 top leaders and stakeholders from the biopharma industry to explore the evolving landscape of pharmacovigilance (PV) and device safety.
This year, TCS is proud to participate as a platinum sponsor, continuing our commitment to advancing innovation in drug safety. Join us at our booth (details coming soon) to connect with our PV experts, gain insights into our deep transformation capabilities, and see firsthand how our purpose-built AI-driven pharmacovigilance platform – TCS ADD™ Safety, is helping global life sciences organizations drive efficiency, ensure compliance, and enhance patient safety.
Keynote Panel discussion:
Topic: Adapting in Real Time: Future-Proofing Pharmacovigilance Through Innovation
Date and time: November 5, 9:20 AM to 10:00 AM ET
In an increasingly dynamic global healthcare landscape, the need for agile, forward-thinking pharmacovigilance systems has never been more urgent. This panel will explore how real-time technologies, predictive analytics, AI/ML tools, and collaborative data ecosystems are revolutionizing the way safety signals are detected, assessed, and acted upon.
Global Head - Advisory and Business Process Services, Life Sciences, Tata Consultancy Services
Sanjeev Sachdeva is the Global Head, - Advisory and Business Process Services, Life Sciences, Tata Consultancy Services. He is responsible for Life Sciences business transformation, research & innovation, advisory and future investments strategy and roadmap. With over 30+ years of experience in technology and business transformation, Sanjeev assists customers in their transformation journey by adopting new innovation technologies and processes across the business value chain - R&D, Manufacturing, Supply Chain, Digital Health, Patient Experience transformation, and Commercials. He has published various industry White Papers in Personalized Medicine, Digital Health, Quantum Computing in Life Sciences, Future of Lab, Blockchain, 5G, Metaverse in Life Sciences and Healthcare, AI in Regulated Industry, and many more.
Presentation - AI track
Topic: Gen-AI, the frontier of a transformative PV change
In this session, we will share a decade of experience and lessons learned in transforming pharmacovigilance (PV) operations using next-generation, AI-driven platforms. We’ll explore key challenges, emerging opportunities, and the latest technological advancements shaping the future of PV. Attendees will have a unique opportunity to engage directly with the TCS team and discover how the current PV landscape can be reimagined through AI. Whether you're eager to harness AI’s potential or curious about its integration with existing practices, this session will offer valuable, real-world insights into this rapidly evolving field.
Industry Leader, TCS ADD™ platform
Dr. Alejandra Guerchicoff is the Industry Leader of the TCS ADD™ platform. She holds a Ph.D. in Molecular Genetics with postdoctoral training in Molecular Cardiology and Genetics of Cardiac Arrhythmias. She has 25 years of experience in medical investigation, clinical trials, and post-marketing pharmacovigilance for medical devices, drugs, combination products, gene and cell therapy, and Software as Medical Device (SaMD) products. She also authored many prestigious journal publications and books on diverse subjects. In her current role, Dr. Guerchicoff is working to develop innovative technology solutions using AI and other modern technologies across various life sciences operations.